tiprankstipranks
Trending News
More News >
Spyre Therapeutics (SYRE)
NASDAQ:SYRE
US Market
Advertisement

Spyre Therapeutics (SYRE) Technical Analysis

Compare
470 Followers

Technical Sentiment

Overall Consensus
Buy
14Bullish
5Neutral
3Bearish
Technical Analysis Consensus
Buy
4Bullish
5Neutral
1Bearish
Moving Average Consensus
Strong Buy
10Bullish
0Neutral
2Bearish
Spyre Therapeutics’s (SYRE) Moving Averages Convergence Divergence (MACD) indicator is 0.14, suggesting Spyre Therapeutics is a Sell.
Spyre Therapeutics’s (SYRE) 20-Day exponential moving average is 16.71, while Spyre Therapeutics’s (SYRE) share price is $17, making it a Buy.
Spyre Therapeutics’s (SYRE) 50-Day exponential moving average is 16.48, while Spyre Therapeutics’s (SYRE) share price is $17, making it a Buy.

Spyre Therapeutics (SYRE) Pivot Points

Sep 06, 2025, 11:57 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
15.27
15.75
16.37
16.85
17.47
17.95
18.57
Fibonacci
15.75
16.17
16.43
16.85
17.27
17.53
17.95
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Spyre Therapeutics (SYRE) Moving Averages

Sep 06, 2025, 11:57 AM
Period
Simple
Exponential
MA5
16.78Buy
16.88Buy
MA10
16.88Buy
16.82Buy
MA20
16.62Buy
16.71Buy
MA50
16.40Buy
16.48Buy
MA100
15.72Buy
16.92Buy
MA200
18.71Sell
20.09Sell
Spyre Therapeutics’s (SYRE) 10-Day exponential moving average is 16.82, while Spyre Therapeutics’s (SYRE) share price is $17, making it a Buy.
Spyre Therapeutics’s (SYRE) 100-Day exponential moving average is 16.92, while Spyre Therapeutics’s (SYRE) share price is $17, making it a Buy.
Spyre Therapeutics’s (SYRE) stock price is $17 and Spyre Therapeutics’s (SYRE) 50-day simple moving average is 16.40, creating a Buy signal.
Spyre Therapeutics’s (SYRE) stock price is $17 and Spyre Therapeutics’s (SYRE) 100-day simple moving average is 15.72, creating a Buy signal.
Spyre Therapeutics’s (SYRE) stock price is $17 and Spyre Therapeutics’s (SYRE) 200-day simple moving average is 18.71, creating a Sell signal.

Spyre Therapeutics (SYRE) Technical Indicators

Sep 06, 2025, 11:57 AM
Name
Value
Implied Action
RSI (14)
53.61
Neutral
STOCH (9,6)
53.18
Neutral
STOCHRSI (14)
58.13
Neutral
MACD (12,26)
0.14
Sell
ADX (14)
12.74
Buy
Williams %R
-38.65
Buy
CCI (14)
78.62
Neutral
ATR (14)
0.88
-
Ultimate Oscillator
46.58
Neutral
ROC
0.29
Buy
Spyre Therapeutics’s (SYRE) Relative Strength Index (RSI) is 53.61, creating a Neutral signal.
Spyre Therapeutics’s (SYRE) Trend Strength Indicator (ADX) is 12.74, creating a Buy signal.
Spyre Therapeutics’s (SYRE) Commodity Channel Index (CCI) is 78.62, creating a Neutral signal.
Spyre Therapeutics’s (SYRE) Price Rate of Change (ROC) is 0.29, creating a Buy signal.

FAQ

Is SYRE a Buy, Hold, or Sell?
Based on SYRE’s technical indicators, SYRE is a Buy.
    What is SYRE’s RSI (14)?
    SYRE’s RSI (14) is 53.61, which suggests SYRE is a Neutral.
      What is SYRE’s MACD?
      SYRE’s MACD is 0.14, which suggests SYRE is a Sell.
        What is SYRE’s 5-day moving average?
        SYRE’s 5-day moving average is 16.78, which suggests SYRE is a Buy.
          What is SYRE’s 20-day moving average?
          SYRE 20-day moving average is 16.62, which suggests SYRE is a Buy.
            What is SYRE’s 50-day moving average?
            SYRE’s 50-day moving average is 16.40, which suggests SYRE is a Buy.
              What is SYRE’s 200-day moving average?
              SYRE’s 200-day moving average is 18.71, which suggests SYRE is a Sell.
                What is SYRE’s Williams % R (14)?
                SYRE’s Williams % R (14) is -38.65, which suggests SYRE is a Buy.
                  What is SYRE’s CCI (14)?
                  SYRE’s CCI (14) is 78.62, which suggests SYRE is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis